Definitive Healthcare Launches Redesigned Mobile App To Enhance Access To Healthcare Commercial Intelligence

7/9/24 9:55:32 AM ET

Computer Software: Prepackaged Software

Technology

Get the next $DH alert in real time by email

Definitive Healthcare (NASDAQ:DH), a leader in healthcare commercial intelligence, today announced the launch of a redesigned mobile app for its popular View Suite platform. The new DH View Suite mobile app provides sales and marketing professionals with on-demand access to vital data and intelligence, maximizing their efficiency and success in the field.

Get the next $DH alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DH

Date	Price Target	Rating	Analyst
9/17/2024	$7.00	Buy	BTIG Research
7/31/2024	$7.00 → $5.00	Neutral → Underweight	JP Morgan
5/8/2024	$11.50 → $9.00	Overweight → Equal-Weight	Morgan Stanley
1/17/2024		Buy → Hold	Needham
1/5/2024		Buy → Hold	Canaccord Genuity
7/24/2023	$13.00	Outperform → Neutral	Robert W. Baird
4/19/2023		Outperform	William Blair
12/9/2022	$13.00	Neutral	BofA Securities

More analyst ratings

$DH
Leadership Updates

Live Leadership Updates

Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth
FRAMINGHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition. "Kevin is an outstanding leader. He has deep, hands-on experience with data-focused businesses and has a
5/28/24 8:00:00 AM ET
$DH
Computer Software: Prepackaged Software
Technology
Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors
Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today. "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth." Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and serv
11/28/23 5:00:00 PM ET
$DH
$GDRX
Computer Software: Prepackaged Software
Technology
EDP Services
Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer
FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. "I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new Chief Revenue Officer," said Robert Musslewhite, Chief Executive Officer of Definitive Healthcare. "Carrie is a fantastic fit for Definitive Healthcare. Her values and her deep belief in the power of humble collaboration make her a perfect match for our culture. Carrie brings a wealth of experience selling Software as a Service to both enterprise accounts and
10/5/23 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology

$DH
Financials

Live finance-specific insights

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
FRAMINGHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights: Revenue was $62.7 million, a decrease of 4% from $65.3 million in Q3 2023. Net Loss, inclusive of goodwill impairment charges of $228.2 million, was $(187.8) million, or (300%) of revenue, down 24% compared to $(248.7) million, inclusive of goodwill impairment charges of $287.4 million, or (381%) of revenue in Q3 2023.Adjusted Ne
11/7/24 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2024, on Thursday, November 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international).
10/24/24 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024
FRAMINGHAM, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights: Revenue was $63.7 million, an increase of 5% from $61.0 million in Q2 2023. Net Loss, inclusive of goodwill impairment charges of $363.6 million, was $(306.2) million, or (480%) of revenue, up 2,538% compared to $(11.6) million, or (19%) of revenue in Q2 2023. Adjusted Net Income was $14.2 million, compared to $12.4 million in Q2 2023. Adjusted EBITDA was $20.9 million, up 21% from
8/5/24 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology

$DH
Press Releases

Fastest customizable press release news feed in the world

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
FRAMINGHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights: Revenue was $62.7 million, a decrease of 4% from $65.3 million in Q3 2023. Net Loss, inclusive of goodwill impairment charges of $228.2 million, was $(187.8) million, or (300%) of revenue, down 24% compared to $(248.7) million, inclusive of goodwill impairment charges of $287.4 million, or (381%) of revenue in Q3 2023.Adjusted Ne
11/7/24 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2024, on Thursday, November 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international).
10/24/24 4:05:00 PM ET
$DH
Computer Software: Prepackaged Software
Technology
Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations
FRAMINGHAM, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This solution is designed to enhance conference planning and participation for life science organizations by providing medical affairs, marketing, and conference planning teams with rich, contextualized conference data and access to the experts driving conference activities. By delivering a comprehensive overview of key conference insights—including information about presenters, timing, and locations of the most relevant scientific and medical updates—Monocl Conferences can help biopharma and medtech organ
10/17/24 9:05:00 AM ET
$DH
Computer Software: Prepackaged Software
Technology

Definitive Healthcare Launches Redesigned Mobile App To Enhance Access To Healthcare Commercial Intelligence

Chat with this insight

Recent Analyst Ratings for $DH

$DH Leadership Updates

Live Leadership Updates

Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth

Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer

$DH Financials

Live finance-specific insights

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024

Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024

$DH Press Releases

Fastest customizable press release news feed in the world

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024

Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast

Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations

$DH Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$DH Large Ownership Changes

This live feed shows all institutional transactions in real time.

$DH Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$DH Market Insights

Live Market Insights

BTIG Research initiated coverage on Definitive Healthcare with a new price target

Definitive Healthcare downgraded by JP Morgan with a new price target

Definitive Healthcare downgraded by Morgan Stanley with a new price target

SEC Form SC 13G filed by Definitive Healthcare Corp.

SEC Form SC 13G filed by Definitive Healthcare Corp.

SEC Form SC 13G/A filed by Definitive Healthcare Corp. (Amendment)

CHIEF FINANCIAL OFFICER Booth Richard Douglas was granted 92,379 shares, increasing direct ownership by 18% to 592,759 units (SEC Form 4)

CHIEF FINANCIAL OFFICER Booth Richard Douglas covered exercise/tax liability with 3,811 shares, decreasing direct ownership by 0.76% to 500,380 units (SEC Form 4)

Chief Product & Tech Officer Moschella William covered exercise/tax liability with 3,587 shares, decreasing direct ownership by 0.74% to 478,830 units (SEC Form 4)

Definitive Healthcare Launches Redesigned Mobile App To Enhance Access To Healthcare Commercial Intelligence

Definitive Healthcare Appoints Kevin Coop As CEO, Effective June 24, 2024

Deutsche Bank Maintains Hold on Definitive Healthcare, Lowers Price Target to $7

$DH SEC Filings

SEC Form 10-Q filed by Definitive Healthcare Corp.

Definitive Healthcare Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Other Events, Financial Statements and Exhibits

SEC Form 8-K filed by Definitive Healthcare Corp.

Recent Analyst Ratings for
$DH

$DH
Leadership Updates

$DH
Financials

$DH
Press Releases

$DH
Analyst Ratings

$DH
Large Ownership Changes

$DH
Insider Trading

$DH
Market Insights

$DH
SEC Filings